CIK 0000897448
- Accelerated filer
AMARIN CORP PLC\UK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-30 | Kennedy Joseph T General Counsel | Sale | −105,039 | $3.98 | $418K | 51,104 |
| 2017-06-29 | Kennedy Joseph T General Counsel | Sale | −151,768 | $3.98 | $604K | 130,591 |
| 2016-11-09 | Kennedy Joseph T General Counsel | Sale | −122,358 | $3.04 | $372K | 162,120 |
| 2012-10-01 | Zakrzewski Joseph S Chief Executive Officer | Sale | −150,000 | $12.56 | $1.9M | 111,937 |
| 2012-09-04 | GORDON CARL L Director | Sale | −231,456 | $14.43 | $3.3M | 594,300 |
| 2012-09-04 | GORDON CARL L Director | Sale | −2,244 | $14.43 | $32K | 5,700 |
| 2012-09-04 | ORBIMED ADVISORS LLC Director | Sale | −231,456 | $14.43 | $3.3M | 594,300 |
| 2012-09-04 | ORBIMED ADVISORS LLC Director | Sale | −2,244 | $14.43 | $32K | 5,700 |
| 2012-07-27 | Zakrzewski Joseph S Chief Executive Officer | Sale | −71,946 | $14.58 | $1.0M | 189,991 |
| 2012-07-27 | Zakrzewski Joseph S Chief Executive Officer | Sale | −78,054 | $14.07 | $1.1M | 111,937 |
| 2012-07-27 | THERO JOHN F President | Sale | −150,926 | $14.97 | $2.3M | 9,450 |
| 2012-07-27 | THERO JOHN F President | Sale | −150,000 | $13.71 | $2.1M | 9,450 |
| 2012-07-27 | Kennedy Joseph T Senior VP and General Counsel | Sale | −541 | $14.74 | $8K | 6,409 |
| 2012-07-27 | Kennedy Joseph T Senior VP and General Counsel | Sale | −6,409 | $13.78 | $88K | 0 |
| 2012-07-27 | Huff Paul Chief Commercial Officer | Sale | −541 | $14.74 | $8K | 6,409 |
| 2012-07-27 | Huff Paul Chief Commercial Officer | Sale | −6,409 | $13.78 | $88K | 0 |
| 2012-07-27 | SEDLACK STUART D Senior Vice President | Sale | −541 | $14.74 | $8K | 6,409 |
| 2012-07-27 | SEDLACK STUART D Senior Vice President | Sale | −6,409 | $13.78 | $88K | 0 |
| 2012-07-27 | GORDON CARL L Director | Sale | −362,844 | $14.61 | $5.3M | 825,756 |
| 2012-07-27 | GORDON CARL L Director | Sale | −3,456 | $14.61 | $50K | 7,944 |
Page 7 of 14 · 279 trades